Health
Sanofi to sponsor the Olympics in its bid for brand renewal
Sanofi hopes Olympic Games sponsorship will allow it to attract new talent, reward existing staff and shake off its conservative image. The French drugmaker said
Salmonella tests at melon plant in Mexico come back negative amid outbreak
Tests for traces of salmonella at a melon processing plant in Mexico came back negative amid an investigation into a deadly outbreak in the United
China approves Eisai and Biogen’s treatment for Alzheimer’s disease
Eisai and Biogen said that their Alzheimer’s disease drug Lecembi has won approval in China, the third country after the US and Japan. Both companies
BioNTech expects to return to revenue growth by 2025
BioNTech said it would return to revenue growth by 2025, predicting that the ongoing decline of its COVID-19 vaccine business would bottom out and that
The US FDA has refused to approve Astellas’ stomach cancer drug
Japan’s Astellas Pharma said the US Food and Drug Administration has refused to approve its experimental drug to treat a type of stomach cancer, citing
GSK boosts respiratory portfolio with $1.4bn Aiolos Bio deal
GSK said on Tuesday it will acquire asthma drug maker Aiolos Bio in a deal worth up to $1.4bn, as the British drugmaker boosts its
Moderna meets preliminary 2023 COVID vaccine sales target
Moderna reported preliminary 2023 sales of $6.7 billion of its COVID vaccine, exceeding the lower end of its full-year forecast, while reiterating its goal of
Florida’s abortion rights law could go before voters
A state constitutional amendment that would protect access to abortion in Florida has received enough signatures of support to appear on the ballot in the
Bayer’s menopause relief drug succeeds in late-stage trial
Bayer says its menopause relief drug has eased hot flashes and improved sleep in two late-stage studies. This is much-needed good news for the German
JN.1 variant accounts for 62% of COVID cases in US
The Centers for Disease Control and Prevention (CDC) stated that the JN.1 subvariant of COVID accounts for approximately 62% of reported cases in the U.S.